Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by fundtraderon Oct 11, 2016 9:21pm
68 Views
Post# 25333176

RE:RE:RE:RE:Buying back 20% of float is a prudent move..

RE:RE:RE:RE:Buying back 20% of float is a prudent move..
Lettuce stop making fake assumptions and numbers out of thin air..I am sure there will be some impact cause of the fx effect, but most of it is hedged at much higher rates. Pound will eventually come back up and numbers might go back to a 600 million ..You are totally ignoring growth, new products, new cash infusion to buy new companies with more revenue etc etc...at $4.30 us This is trading more like a Research and Development firm that has 0 revenue and a drug or 2 in pipeline. The fact is that they got over 200 drugs and and a monopoly on more then 50 of them. They are generating close to 900 million in annual revenues and have adjusted Ebidita of over 500 million $.
<< Previous
Bullboard Posts
Next >>